The Field Offering 65% Subscribed on Fineqia Investment Platform
LONDON, Feb. 6, 2018 /CNW/ - Fineqia International Inc., (the "Company" or "Fineqia") (CSE: FNQ) (OTCPink: FNQQF) (Frankfurt: FNQA) is pleased to announce that 65% of the minimum offering of The Field available on the platform of its U.K. subsidiary Fineqia Ltd, has been subscribed.
The Field, an action-drama and independent picture set in New Delhi, India, had raised approx. US$2.3 million and tapped into the Fineqia platform to complete its financing round to help take the movie to completion. Shooting of the film has already been completed with 36 days of filming in Los Angeles, New Delhi and Mumbai. Post-production work remains to take the film to completion.
Starring Hollywood actor Brendan Fraser, Indian film stars Abhay Deol, Ronit Roy, Prem Chopra and French actress Charlotte Poutrel, The Field centers on a mafia family at war with one another and an undercover officer who assists in their downfall. With its dark criminal undertones, the movie can be likened to cult gangster movie classics in both Western and Indian cinema.
"We couldn't be happier that people are discovering the project and believe in it as passionately as we do," said The Field's Director, Rohit Batra. "We look forward to finishing the film and engaging with audiences across the globe."
The minimum amount to be raised on the Fineqia platform was US$100,000 for 1.6 units of equity in The Field LLC, a California limited company. At this point, US$65,000 has been raised via the Fineqia platform, equivalent to 1.04 units of equity, for which Fineqia Ltd receives a placement fee. The minimum investment amount is GBP1,000 or US$1,400 at prevailing exchange rates.
Eligible investors can find further details of the offering on the Fineqia platform at www.fineqia.com.
About Fineqia Limited
Fineqia provides a platform and associated services to support security issuances and manage administration of equity and debt securities. It acts as a broker bringing an issuing company's securities to market, distributing and marketing them as well as transparently highlighting the risks and objectively outlining opportunities involved. It recently announced the incorporation of blockchain technologies to achieve these objectives. For more information visit www.fineqia.com
Residents of Canadian jurisdictions are not able to subscribe for equity or debt securities on the Fineqia platform unless and until Fineqia has become registered in the Canadian jurisdiction as a dealer under applicable securities laws. Investors resident in other jurisdictions outside of the European Union may also be restricted from participating in offerings on the Fineqia platform. We will allow for participation of investors resident outside of the European Union when Fineqia has received the requisite regulatory approvals.
Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Fineqia Ltd is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Fineqia Ltd once you are registered as sufficiently sophisticated. This page is communicated by Fineqia Ltd and has been approved as a financial promotion by Kession Capital Ltd. Fineqia Ltd, is an appointed representative of Kession Capital Ltd who are authorised and regulated by the Financial Conduct Authority. Investment are not offers of guaranteed returns and investments can only be made by members via Fineqia Ltd on the basis of information provided in the pitches by the companies concerned. Fineqia Ltd takes no responsibility for this information or for any recommendations or opinions made by the companies. Your capital is at risk.
Some statements in this release may contain forward-looking information (as defined under applicable Canadian securities laws) ("forward-looking statements"). All statements, other than of historical fact, that address activities, events or developments that Fineqia (the "Company") believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement except to the extent required by applicable securities laws.
Fineqia Limited (FRN: 757772) is an appointed representative of Kession Capital Limited (FRN: 582160), which is authorised and regulated by the Financial Conduct Authority in the UK.
SOURCE Fineqia International Inc.
Upcoming Life Sciences Events
- August 2018
- Boston: The Bioprocessing Summit 2018
- Boston: Immuno-Oncology Summit
- September 2018
- Wellington: Life Science Venture Valuation Workshop